Literature DB >> 1185134

A critical review of periodic health screening using specific screening criteria. Part 4: selected miscellaneous diseases.

P S Frame, S J Carlson.   

Abstract

Despite the increasing interest in recent years in prevention and early recognition of asymptomatic disease, an objectively based program for periodic health screening of asymptomatic adults has yet to be proposed for the primary care physician. This is the last in a series of four articles which have critically examined the feasibility of screening procedures for 36 selected diseases. Six basic criteria are adopted as necessary to justify periodic screening. Specific screening recommendations are made for each disease, and a longitudinal screening program for asymptomatic adults is proposed. Cost and patient education are two important factors in any viable screening program.

Entities:  

Mesh:

Year:  1975        PMID: 1185134

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  7 in total

1.  The periodic health examination.

Authors:  P P Morgan
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Screening for diabetes--an alternative view.

Authors:  G Worrall
Journal:  Br J Gen Pract       Date:  1992-07       Impact factor: 5.386

3.  Identification and Prevention: Underutilized Tools in Diabetes Treatment?

Authors:  Stephen A Brunton
Journal:  Clin Diabetes       Date:  2014-01

4.  Cancer screening in older adults.

Authors:  J M Walsh
Journal:  West J Med       Date:  1992-05

5.  Tools for the Job: The POMR in Preventive Medicine.

Authors:  B Dixon-Warren
Journal:  Can Fam Physician       Date:  1977-06       Impact factor: 3.275

Review 6.  Opportunities for health promotion and disease prevention in the clinical setting.

Authors:  J M McGinnis; M A Hamburg
Journal:  West J Med       Date:  1988-10

7.  Family Medicine Research in the United States From the late 1960s Into the Future.

Authors:  Marjorie A Bowman; Sean C Lucan; Thomas C Rosenthal; Arch G Mainous; Paul A James
Journal:  Fam Med       Date:  2017-04       Impact factor: 1.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.